共 40 条
The Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and PainDETECT Questionnaires in COVID-19 Survivors with Post-COVID Pain
被引:10
作者:
Fernandez-de-las-Penas, Cesar
[1
,2
]
Antonio Valera-Calero, Juan
[3
,4
]
Herrero-Montes, Manuel
[5
,6
]
del-Valle-Loarte, Pablo
[7
]
Rodriguez-Rosado, Rafael
[7
]
Ferrer-Pargada, Diego
[8
]
Arendt-Nielsen, Lars
[2
,9
]
Paras-Bravo, Paula
[5
,6
]
机构:
[1] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Madrid 28922, Spain
[2] Aalborg Univ, Fac Med, Ctr Neuroplast & Pain CNAP, SMI,Dept Hlth Sci & Technol, DK-9220 Aalborg, Denmark
[3] Univ Camilo Jose Cela, Fac Hlth, Dept Physiotherapy, Villanueva De La Canada 28692, Spain
[4] Camilo Jose Cela Univ, Fac Hlth, Dept Physiotherapy, VALTRADOFI Res Grp, Villanueva De La Canada 28692, Spain
[5] Univ Cantabria, Dept Enfermeria, Santander 39008, Spain
[6] Inst Invest Sanitaria Valdecilla IDIVAL, Grp Invest Enfermeria, Santander 39011, Spain
[7] Hosp Univ Severo Ochoa, Dept Internal Med, Leganes 28911, Spain
[8] Hosp Univ Marques Valdecilla, Serv Neumol, Santander 39008, Spain
[9] Aalborg Univ Hosp, Dept Med Gastroenterol, Mech Sense, DK-9000 Aalborg, Denmark
来源:
VIRUSES-BASEL
|
2022年
/
14卷
/
07期
关键词:
COVID-19;
pain;
long-COVID;
neuropathic;
S-LANSS;
PainDETECT;
CENTRAL SENSITIZATION INVENTORY;
VALIDATION;
SCALE;
PHENOTYPE;
VERSION;
D O I:
10.3390/v14071486
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
This study aimed to analyze correlations between Self-Report Leeds Assessment of Neuropathic Symptoms (S-LANSS) and PainDETECT with proxies of sensitization, pain-related, or psychological/cognitive variables in coronavirus disease, 2019 (COVID-19) survivors exhibiting post-COVID pain. Demographic, clinical, psychological, cognitive, sensitization-associated symptoms, and health-related quality of life were collected in 146 survivors with post-COVID pain. The PainDETECT and S-LANSS questionnaires were used for assessing neuropathic pain-related symptoms. Patients were assessed with a mean of 18.8 (SD 1.8) months after hospitalization. Both questionnaires were positively associated with pain intensity (p < 0.05), anxiety (PainDETECT p < 0.05; S-LANSS p < 0.01), sensitization-associated symptoms (p < 0.01), catastrophism (p < 0.01), and kinesiophobia (p < 0.01) and negatively associated with quality of life (PainDETECT p < 0.05; S-LANSS p < 0.01). Depressive levels were associated with S-LANSS (p < 0.05) but not with PainDETECT. The stepwise regression analyses revealed that 47.2% of S-LANSS was explained by PainDETECT (44.6%), post-COVID pain symptoms duration (1.7%), and weight (1.1%), whereas 51.2% of PainDETECT was explained by S-LANSS (44.6%), sensitization-associated symptoms (5.4%), and anxiety levels (1.2%). A good convergent association between S-LANSS and PainDETECT was found. Additionally, S-LANSS was associated with symptom duration and weight whereas PainDETECT was associated with sensitization-associated symptoms and anxiety levels, suggesting that the two questionnaires evaluate different aspects of the neuropathic pain spectrum in post-COVID pain patients.
引用
收藏
页数:11
相关论文